Faeth Therapeutics, Inc. (FTH)

34.50 -0.63 (-1.79%) USD  |  NASDAQ  |  Sep 18, 16:00
34.47 -0.03 (-0.09%) After-Hours: 20:00
More

Faeth Therapeutics EPS Estimates for Current Quarter

EPS Estimates for Current Quarter Chart

View EPS Estimates for Current Quarter for FTH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Current Quarter Chart
Start Trial

Historical EPS Estimates for Current Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
September 15, 2026 --
August 10, 2026 --
October 17, 2025 --
September 30, 2025 --
August 05, 2025 --
July 07, 2025 --
June 30, 2025 --
June 27, 2025 --
May 07, 2025 --
March 31, 2025 --
Date Value
January 10, 2025 --
December 31, 2024 --
December 05, 2024 --
November 14, 2024 --
October 03, 2024 --
September 30, 2024 --
August 16, 2024 --
August 07, 2024 --
August 06, 2024 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Current Quarter Range, Past 5 Years

View EPS Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Current Quarter Benchmarks

View EPS Estimates for Current Quarter Benchmarks
Start Trial
Opus Genetics, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Praxis Precision Medicines, Inc. Upgrade
Nuvectis Pharma, Inc. --
Jade Biosciences, Inc. Upgrade

EPS Estimates for Current Quarter Related Metrics

EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade